Mechanism and Function of a Newly Identified CpG DNA Motif in Human Primary B Cells

Cited by (605)

Items 101–200 of 605

1. A tale of two sites: how inflammation can reshape the microbiomes of the gut and lungs
   Scales, Brittan S, Dickson, Robert P, Huffnagle, Gary B · 2016 · Journal of Leukocyte Biology
2. The role of CpG motifs in immunostimulation and gene therapy
   Ronald K. Scheule · 2000 · Advanced Drug Delivery Reviews
3. Contribution of IRF5 in B cells to the development of murine SLE-like disease through its transcriptional control of the IgG2a locus
   David A. Savitsky, Hideyuki Yanai, Tomohiko Tamura, Tadatsugu Taniguchi, Kenya Honda · 2010 · Proceedings of the National Academy of Sciences
4. TLR9 and the Recognition of Self and Non‐Self Nucleic Acids
   Marc S. Lamphier, Cherilyn M. Sirois, Anjali Verma, Douglas Taylor Golenbock, Eicke Latz · 2006 · Annals of the New York Academy of Sciences
5. CpG oligonucleotides enhance the tumor antigen-specific immune response of a granulocyte macrophage colony-stimulating factor-based vaccine strategy in neuroblastoma.
   Anthony David Sandler, Hiroshi Chihara, Gen Kobayashi, Xiaoyan Zhu, Michal Ann Miller, David Lloyd Scott, Arthur Μ. Krieg · 2003 · PubMed
6. Bacterial DNA activates human neutrophils by a CpG‐independent pathway
   Analia Silvina Trevani, Alejo Chorny, Gabriela Verónica Salamone, Monica Elba Vermeulen, Romina Gamberale, Jorge L. Schettini, Silvina Raiden, Jorge Raul Geffner · 2003 · European Journal of Immunology
7. Staphylococcus aureus Protein A Triggers T Cell-Independent B Cell Proliferation by Sensitizing B Cells for TLR2 Ligands
   Isabelle Bekeredjian‐Ding, Seiichi Inamura, Thomas Giese, Hermann Moll, Stefan Endres, Andreas Sing, Ulrich Zähringer, Gunther Hartmann · 2007 · The Journal of Immunology
8. Delayed Hypersensitivity to Tuberculin, Total Immunoglobulin E, Specific Sensitization, and Atopic Manifestation in Longitudinally Followed Early Bacille Calmette-Guerin-Vaccinated and Nonvaccinated Children
   Christoph Grüber, Michael Kulig, Renate L. Bergmann, I. Guggenmoos-Holzmann, Ulrich Wahn, the MAS-90 Study Group · 2001 · PEDIATRICS
9. Presence and role of cytosine methylation in DNA viruses of animals
   Karin Hoelzer, Laura A. Shackelton, Colin R. Parrish · 2008 · Nucleic Acids Research
10. CpG Oligodeoxyneucleotides as TLR9 Agonists
    Yanal M. Murad, Timothy M. Clay · 2009 · BioDrugs
11. CpG DNA as a vaccine adjuvant
    Dennis M. Klinman · 2003 · Expert Review of Vaccines
12. Bacterial DNA in House and Farm Barn Dust
    S Roy · 2003 · Journal of Allergy and Clinical Immunology
13. Serum and mucosal antibody responses to pneumococcal protein antigens in children:relationships with carriage status
    Qibo Zhang, Jolanta Bernatoniene, Linda Bagrade, Andrew John Pollard, Timothy J. Mitchell, James C. Paton, Adam H.R. Finn · 2005 · European Journal of Immunology
14. A distinct Toll‐like receptor repertoire in human tonsillar B cells, directly activated by Pam3CSK4, R‐837 and CpG‐2006 stimulation
    Anne Månsson, Mikael Adner A, Ulf Höckerfelt, Lars‐Olaf Cardell · 2006 · Immunology
15. Conjugate Vaccine Immunotherapy for Substance Use Disorder
    Paul T. Bremer, Kim D. Janda · 2017 · Pharmacological Reviews
16. RNA Recognition via TLR7 and TLR8
    Veit Hornung, Winfried Barchet, Martin Schlee, Gunther Hartmann · 2007 · Handbook of experimental pharmacology
17. Development of a Clinically Viable Heroin Vaccine
    Paul T. Bremer, Joel E. Schlosburg, Matthew L. Banks, Floyd F. Steele, Bin Zhou, Justin L. Poklis, Kim D. Janda · 2017 · Journal of the American Chemical Society
18. CpG-induced immunomodulation and intracellular bacterial killing in a chicken macrophage cell line
    Hang Xie, Richard B. Raybourne, Uma S. Babu, Hyun Soon Lillehoj, Robert A. Heckert · 2003 · Developmental & Comparative Immunology
19. CpG Oligodeoxynucleotides Modulate the Osteoclastogenic Activity of Osteoblasts via Toll-like Receptor 9
    Wei Zou, Alla Amcheslavsky, Zvi Bar‐Shavit · 2003 · Journal of Biological Chemistry
20. Clinical Evaluation of Safety and Immunogenicity of PADRE-Cytomegalovirus (CMV) and Tetanus-CMV Fusion Peptide Vaccines With or Without PF03512676 Adjuvant
    Corinna La Rosa, Jeff Longmate, Simon Francis Lacey, Teodora I. Kaltcheva, Rahul Sharan, Denise Marsano, Peter D. Kwon, Jennifer Drake, Brenda Williams, S. Denison et al. · 2012 · The Journal of Infectious Diseases
21. Lactoferrin Binds CpG-Containing Oligonucleotides and Inhibits Their Immunostimulatory Effects on Human B Cells
    Bradley E. Britigan, Troy S. Lewis, Mari M. Waldschmidt, Michael L. McCormick, Arthur Μ. Krieg · 2001 · The Journal of Immunology
22. CpG oligonucleotides improve the protective immune response induced by the anthrax vaccination of rhesus macaques
    Dennis M. Klinman, Hang Xie, Stephen F. Little, Debra Currie, Bruce E. Ivins · 2004 · Vaccine
23. Conditional Immortalization of Human B Cells by CD40 Ligation
    Martina Wiesner, Caroline Zentz, Christine Mayr, Rainer Wimmer, Wolfgang Hammerschmidt, Reinhard Zeidler, Andreas Moosmann · 2008 · PLoS ONE
24. Gut health benefit and application of postbiotics in animal production
    Yifan Zhong, Shanshan Wang, Hanqiu Di, Zhaoxi Deng, Jianxin Liu, Haifeng Wang · 2022 · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology
25. Optimization and delivery of plasmid DNA for vaccination
    Wolfgang Jechlinger · 2006 · Expert Review of Vaccines
26. Minimal toxicity of stabilized compacted DNA nanoparticles in the murine lung
    Assem G. Ziady, Christopher R. Gedeon, Osman Muhammad, Virginia Stillwell, Sharon M. Oette, Tamara L. Fink, Will Quan, Tomasz H Kowalczyk, Susannah L. Hyatt, Jennifer M. Payne et al. · 2003 · Molecular Therapy
27. Mycobacterium tuberculosis 19-kDa Lipoprotein Promotes Neutrophil Activation
    Clemens F. Neufert, Rish K. Pai, Erika H. Noss, Melvin Berger, W. Henry Boom, Clifford V. Harding · 2001 · The Journal of Immunology
28. Cytoplasmic Targeting Motifs Control Localization of Toll-like Receptor 9
    Cynthia Anne Leifer, James C. Brooks, Karin Hoelzer, Jody L. Lopez, Margaret N. Kennedy, Alessandra Mazzoni, David M. Segal · 2006 · Journal of Biological Chemistry
29. CpG oligodeoxynucleotides activate grass carp (Ctenopharyngodon idellus) macrophages
    Zhen Meng, Jianzhong Shao, Lixin Xiang · 2003 · Developmental & Comparative Immunology
30. Altered Toll-Like Receptor 9 Responses in Circulating B Cells at the Onset of Extensive Chronic Graft-versus-Host Disease
    Kevin She, Andrew Lee Gilman, Soudabeh Aslanian, Hiromi Shimizu, Mark Krailo, Zhengjia Chen, Gregor S. D. Reid, Donna Ann Wall, Fred Goldman, Kirk R. Schultz · 2007 · Transplantation and Cellular Therapy
31. Use of Human Hybridoma Technology To Isolate Human Monoclonal Antibodies
    Scott Alan Smith, James E. Crowe · 2015 · Microbiology Spectrum
32. Injection Route and TLR9 Agonist Addition Significantly Impact Heroin Vaccine Efficacy
    Paul T. Bremer, Joel E. Schlosburg, Jenny M. Lively, Kim D. Janda · 2014 · Molecular Pharmaceutics
33. Necessity of Oligonucleotide Aggregation for Toll-like Receptor 9 Activation
    Christina C. N. Wu, Jong‐Dae Lee, Eyal Raz, Maripat Corr, Dennis Anthony Carson · 2004 · Journal of Biological Chemistry
34. Human B Cell Responses to TLR Ligands Are Differentially Modulated by Myeloid and Plasmacytoid Dendritic Cells
    Iyadh Douagi, Cornelia Gujer, Christopher Sundling, William C. T. Adams, Anna Smed‐Sörensen, Robert A. Seder, Gunilla B. Karlsson Hedestam, Karin Loré · 2009 · The Journal of Immunology
35. CpG DNA-mediated immune response in pulmonary endothelial cells
    Jiang Li, Zheng Ma, Zhi-Lue Tang, Troy Stevens, Bruce R. Pitt, Song Li · 2004 · American Journal of Physiology-Lung Cellular and Molecular Physiology
36. Therapeutic Applications of Synthetic CpG Oligodeoxynucleotides as TLR9 Agonists for Immune Modulation
    Marion Jurk, Jörg Vollmer · 2007 · BioDrugs
37. Comparative analysis of murine marrow–derived dendritic cells generated by Flt3L or GM-CSF/IL-4 and matured with immune stimulatory agents on the in vivo induction of antileukemia responses
    Brenda J. Weigel, Narender Nath, Patricia A. Taylor, Angela Panoskaltsis‐Mortari, Wei Chen, Arthur Μ. Krieg, Kenneth Brasel, Bruce R. Blazar · 2002 · Blood
38. CpG ODN Nanorings Induce IFNα from Plasmacytoid Dendritic Cells and Demonstrate Potent Vaccine Adjuvant Activity
    Bilgi Gungor, Fuat Cem Yağcı, Gizem Tincer, Banu Bayyurt, Esin Alpdundar, Soner Yildiz, Mine Özcan, İhsan Gürsel, Mayda Gürsel · 2014 · Science Translational Medicine
39. Enhancement of Infectious Disease Vaccines Through TLR9-Dependent Recognition of CpG DNA
    Michael J. McCluskie, ARTHUR M. KRIEG · 2006 · Springer eBooks
40. CpG ODN enhance antigen-specific NKT cell activation via plasmacytoid dendritic cells
    Anja Marschner, Simon Rothenfußer, Veit Hornung, Domenik Prell, Anne Krug, Miren Kerkmann, Daniela Wellisch, Hendrik Poeck, Andreas Greinacher, Thomas Giese et al. · 2005 · European Journal of Immunology
41. Synthetic unmethylated cytosine-phosphate-guanosine oligodeoxynucleotides are potent stimulators of antileukemia responses in naive and bone marrow transplant recipients
    Bruce R. Blazar, Arthur Μ. Krieg, Patricia A. Taylor · 2001 · Blood
42. Immunoregulatory activity of CpG oligonucleotides in humans and nonhuman primates
    Daniela I. Verthelyi, Dennis M. Klinman · 2003 · Clinical Immunology
43. Strong Cytosine-Guanosine-Independent Immunostimulation in Humans and Other Primates by Synthetic Oligodeoxynucleotides with PyNTTTTGT Motifs
    Fernanda Elı́as, Juan Fló, Ricardo A. López, Jorge Zorzópulos, Alejandro D. Montaner, Juan M Rodriguez · 2003 · The Journal of Immunology
44. C-Class CpG ODN: sequence requirements and characterization of immunostimulatory activities on mRNA level
    Marion Jurk, Bettina Schulte, Andrea Kritzler, Bernhard O. Noll, Eugen Uhlmann, Tanja Wader, Christian Schetter, Arthur Μ. Krieg, Jörg Vollmer · 2004 · Immunobiology
45. CXCL16 Influences the Nature and Specificity of CpG-Induced Immune Activation
    Mayda Gürsel, İhsan Gürsel, Howard S. Mostowski, Dennis M. Klinman · 2006 · The Journal of Immunology
46. CpG-ODN-induced nitric oxide production is mediated through clathrin-dependent endocytosis, endosomal maturation, and activation of PKC, MEK1/2 and p38 MAPK, and NF-κB pathways in avian macrophage cells (HD11)
    Haiqi He, Michael H. Kogut · 2003 · Cellular Signalling
47. Tumor destruction using electrochemotherapy followed by CpG oligodeoxynucleotide injection induces distant tumor responses
    Stephan Roux, Claire Bernat, Bassim Al-Sakere, François Ghiringhelli, Paule Opolon, Antoine F. Carpentier, Laurence Zitvogel, Lluis M. Mir, Caroline Robert · 2008 · Cancer Immunology Immunotherapy
48. Prime-Boost Vaccination with HIV-1 Gag Protein and Cytosine Phosphate Guanosine Oligodeoxynucleotide, Followed by Adenovirus, Induces Sustained and Robust Humoral and Cellular Immune Responses
    Marc Tritel, Amy M. Stoddard, Barbara J. Flynn, Patricia A. Darrah, Chang You Wu, Ulrike Wille, Javeed Ali Shah, Yue Huang, Ling Xu, Michael R. Betts et al. · 2003 · The Journal of Immunology
49. B Cell-Derived IL-15 Enhances CD8 T Cell Cytotoxicity and Is Increased in Multiple Sclerosis Patients
    Raphaël Schneider, Alma N. Mohebiany, Igal Ifergan, Diane Beauseigle, Pierre Duquette, Alexandre Prat, Nathalie Arbour · 2011 · The Journal of Immunology
50. Recognition of nucleic acid and nucleic acid analogs by Toll-like receptors 7, 8 and 9
    Stefan Bauer, Stephanie Pigisch, Doris Hangel, Andreas Martin Kaufmann, Svetlana Hamm · 2007 · Immunobiology
51. Lipopolysaccharide and CpG DNA synergize for tumor necrosis factor-α production through activation of NF-κB
    Ae‐Kyung Yi, Jae-Geun Yoon, Soon–Cheol Hong, Thomas W. Redford, Arthur Μ. Krieg · 2001 · International Immunology
52. Immune Mechanisms and Therapeutic Potential of CpG Oligodeoxynucleotides
    Heather L. Wilson, Arshud M. Dar, Scott Napper, A. Marianela Lopez, Lorne A. Babiuk, George Mutwiri · 2006 · International Reviews of Immunology
53. β-Glucan–Activated Human B Lymphocytes Participate in Innate Immune Responses by Releasing Proinflammatory Cytokines and Stimulating Neutrophil Chemotaxis
    Mohamed F. Ali, Christopher B. Driscoll, P. Walters, ANDREW HAR LIMPER, Eva M. Carmona · 2015 · The Journal of Immunology
54. CpG-A Oligonucleotides Induce a Monocyte-Derived Dendritic Cell-Like Phenotype That Preferentially Activates CD8 T Cells
    Anne Krug, Simon Rothenfußer, S. Selinger, C Bock, Miren Kerkmann, Julia Battiany, Anja Sarris, Thomas Giese, Daniel E. Speiser, Stefan Endres et al. · 2003 · The Journal of Immunology
55. Distribution and kinetics of SR-PSOX/CXCL16 and CXCR6 expression on human dendritic cell subsets and CD4+ T cells
    Sumie Tabata, Norimitsu Kadowaki, Toshio Kitawaki, Takeshi Shimaoka, Shin Yonehara, Osamu Yoshie, Takashi Uchiyama · 2005 · Journal of Leukocyte Biology
56. Monocytes are required for optimum in vitro stimulation of bovine peripheral blood mononuclear cells by non-methylated CpG motifs
    Reno A. Pontarollo, Robert Rankin, Lorne A. Babiuk, Dale L. Godson, Philip John Griebel, Rolf Hecker, ARTHUR M. KRIEG, Sylvia van Drunen Littel‐van den Hurk · 2002 · Veterinary Immunology and Immunopathology
57. Immunostimulatory CpG motifs in the genomes of gut bacteria and their role in human health and disease
    Ravi Kant, Willem M. de Vos, Airi Palva, Reetta M. Satokari · 2013 · Journal of Medical Microbiology
58. Recent advances in the development of immunostimulatory oligonucleotides.
    Eugen Uhlmann, Joerg Vollmer · 2003 · PubMed
59. Oligonucleotide containing CpG motifs enhances immune response to mucosally or systemically administered tetanus toxoid
    Jean W. Eastcott, Cynthia J. Holmberg, Floyd E. Dewhirst, Thomas R. Esch, Daniel J. Smith, Martin A. Taubman · 2001 · Vaccine
60. Human monocyte-derived dendritic cells express TLR9 and react directly to the CpG-A oligonucleotide D19
    Victoria Hoene, Matthias Peiser, Reinhard Wanner · 2006 · Journal of Leukocyte Biology
61. Modulation of malignant B cell activation and apoptosis by bcl-2 antisense ODN and immunostimulatory CpG ODN
    Bernd Jahrsdörfer, Ralf J. Jox, Lars Mühlenhoff, Katharina Tschoep, Anne Krug, Simon Rothenfußer, G Meinhardt, Bertold Emmerich, Stefan Endres, Gunther Hartmann · 2002 · Journal of Leukocyte Biology
62. TLR9 in Health and Disease
    Jörg Vollmer · 2006 · International Reviews of Immunology
63. Toll-like receptor-mediated innate immunity against herpesviridae infection: a current perspective on viral infection signaling pathways
    Wenjin Jim Zheng, Qing Xu, Yiyuan Zhang, E Xiaofei, Wei Gao, Mogen Zhang, Weijie Zhai, Ronaldjit Singh Rajkumar, Zhijun Liu · 2020 · Virology Journal
64. Superior Activity of the Type C Class of ISS In Vitro and In Vivo Across Multiple Species
    Jason D. Marshall, Karen L. Fearon, Debbie Higgins, Edith M. Hessel, Holger Kanzler, Christi Abbate, Priscilla Yee, Josh D. Gregorio, Tracy dela Cruz, Jennifer O. Lizcano et al. · 2005 · DNA and Cell Biology
65. Functional‐DNA‐Driven Dynamic Nanoconstructs for Biomolecule Capture and Drug Delivery
    Jinhwan Kim, Donghyun Jang, Hyeongmok Park, Sung‐Jin Jung, Dae Heon Kim, Won Jong Kim · 2018 · Advanced Materials
66. CD40‐dependent and ‐independent activation of human tonsil B cells by CpG oligodeoxynucleotides
    Florian Gantner, Patrice Hermann, Kosuke Nakashima, Satoko Matsukawa, Katsuya Sakai, Kevin B. Bacon · 2003 · European Journal of Immunology
67. EBV Infection Empowers Human B Cells for Autoimmunity: Role of Autophagy and Relevance to Multiple Sclerosis
    Elena Morandi, S. Anwar Jagessar, Bert A. ‘t Hart, Bruno Gran · 2017 · The Journal of Immunology
68. NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated components
    Federico Pozzo, Tamara Bittolo, Elena Vendramini, Riccardo Bomben, Pietro Bulian, Francesca Maria Rossi, Antonella Zucchetto, Erika Tissino, Massimo Degan, Giovanni Francesco D'Arena et al. · 2017 · Leukemia
69. Immune Cell-Mediated Antitumor Activities of GD2-Targeted Liposomal c-myb Antisense Oligonucleotides Containing CpG Motifs
    Chiara Brignole, Fabio Pastorino, Danilo Marimpietri, Gabriella Pagnan, Angela Pistorio, Theresa M. Allen, Vito Pistoia, Mirco Ponzoni · 2004 · JNCI Journal of the National Cancer Institute
70. From Bugs to Drugs: Therapeutic Immunomodulation with Oligodeoxynucleotides Containing CpG Sequences from Bacterial DNA
    Arthur Μ. Krieg · 2001 · Antisense and Nucleic Acid Drug Development
71. Differential induction of innate anti-viral responses by TLR ligands against Herpes simplex virus, type 2, infection in primary genital epithelium of women
    Aisha Nazli, Xiao-Dan Yao, Marek Smieja, Kenneth Lee Rosenthal, Ali A. Ashkar, Charu Kaushic · 2008 · Antiviral Research
72. Immunostimulatory DNA as a vaccine adjuvant
    Debbie Higgins, Jason D. Marshall, Paula Traquina, Gary Van Nest, Brian D. Livingston · 2007 · Expert Review of Vaccines
73. Highly Immunostimulatory CpG-Free Oligodeoxynucleotides for Activation of Human Leukocytes
    Jörg Vollmer, Andrea Janosch, Meike Laucht, Zuhair K. Ballas, Christian Schetter, Arthur Μ. Krieg · 2002 · Antisense and Nucleic Acid Drug Development
74. Identification of novel oligonucleotides from mitochondrial DNA that spontaneously induce plasmacytoid dendritic cell activation
    Moritz Ries, Philipp Schuster, Sabrina Thomann, Norbert Donhauser, Jörg Vollmer, Bárbara Schmidt · 2013 · Journal of Leukocyte Biology
75. Distinct Response of Human B Cell Subpopulations in Recognition of an Innate Immune Signal, CpG DNA
    Jaeho Jung, Ae‐Kyung Yi, Xin Zhang, Jongseon Choe, Li Li, Yong Sung Choi · 2002 · The Journal of Immunology
76. Cytotoxic-T-Lymphocyte Human Papillomavirus Type 16 E5 Peptide with CpG-Oligodeoxynucleotide Can Eliminate Tumor Growth in C57BL/6 Mice
    Yifang Chen, Chih-Wei Lin, Yeou‐Ping Tsao, Show‐Li Chen · 2004 · Journal of Virology
77. Interactions of Single and Combined Human Immunodeficiency Virus Type 1 (HIV-1) DNA Vaccines
    Anne Kjerrström, Jorma Hinkula, Gunnel Engström, Vladimir Ovod, Kai J. E. Krohn, Reinhold Benthin, Britta Wahrén · 2001 · Virology
78. Binding Mode of CpG Oligodeoxynucleotides to Nanoparticles Regulates Bifurcated Cytokine induction via Toll-like Receptor 9
    Shanmugavel Chinnathambi, Song Chen, Singaravelu Ganesan, Nobutaka Hanagata · 2012 · Scientific Reports
79. Toll-Like Receptor Agonists Synergistically Increase Proliferation and Activation of B Cells by Epstein-Barr Virus
    Stefanie Iskra, Markus Kalla, Henri‐Jacques Delecluse, Wolfgang Hammerschmidt, Andreas Moosmann · 2010 · Journal of Virology
80. Selectivity of Human TLR9 for Double CpG Motifs and Implications for the Recognition of Genomic DNA
    Jelka Pohar, Chikako Yamamoto, Ryutaro Fukui, Miša Mojca Cajnko, Kensuke Miyake, Roman Jerala, Mojca Benčina · 2017 · The Journal of Immunology
81. Papillomavirus virus‐like particles induce cytokines characteristic of innate immune responses in plasmacytoid dendritic cells
    Petra Lenz, Douglas R. Lowy, John T. Schiller · 2005 · European Journal of Immunology
82. Vitamin A potentiates CpG-mediated memory B-cell proliferation and differentiation: involvement of early activation of p38MAPK
    Aase Ertesvag, Hans‐Christian Aasheim, Soheil Naderi, Heidi Kiil Blomhoff · 2007 · Blood
83. Analysis of Plasmacytoid and Myeloid Dendritic Cells in Nasal Epithelium
    Evelyn Hartmann, Hendrik Graefe, Anne Hopert, Ralph Pries, Simon Rothenfußer, Hendrik Poeck, Brigitte Mack, Stefan Endres, Gunther Hartmann, Barbara Wollenberg · 2006 · Clinical and Vaccine Immunology
84. Modulation of CpG Oligodeoxynucleotide-Mediated Immune Stimulation by Locked Nucleic Acid (LNA)
    Jörg Vollmer, Jan Stenvang, Eugen Uhlmann, Christian Schetter, Marion Jurk, Tanja Wader, Meike Wüllner, Arthur Μ. Krieg · 2004 · Oligonucleotides
85. CpG oligonucleotides: novel regulators of osteoclast differentiation
    W. Zou, H. Schwartz, S. Endres, G. Hartmann, Z. Bar-Shavit · 2002 · The FASEB Journal
86. Minimal Sequence Requirements for Oligodeoxyribonucleotides Activating Human TLR9
    Pohar, Jelka, Kužnik Krajnik, Alenka, Jerala, Roman, Benčina, Mojca · 2015 · The Journal of Immunology
87. Phosphorothioate‐stimulated uptake of short interfering RNA by human cells
    Marita G. Overhoff, Georg Sczakiel · 2005 · EMBO Reports
88. Progress in drug development of immunostimulatory CpG oligodeoxynucleotide ligands for TLR9
    Jörg Vollmer · 2005 · Expert Opinion on Biological Therapy
89. Identification of a boron nitride nanosphere-binding peptide for the intracellular delivery of CpG oligodeoxynucleotides
    Huijie Zhang, Tomohiko Yamazaki, Chunyi Zhi, Nobutaka Hanagata · 2012 · Nanoscale
90. Bovine and Ovine Blood Mononuclear Leukocytes Differ Markedly in Innate Immune Responses Induced by Class A and Class B CpG-Oligodeoxynucleotide
    Angelo Mena, Anil Nichani, Yurij Popowych, Xenia P. Ioannou, Dale L. Godson, George Mutwiri, Rolf Hecker, Lorne A. Babiuk, Philip John Griebel · 2003 · Oligonucleotides
91. In VivoEffects of CpG Oligodeoxynucleotide on Eimeria Infection in Chickens
    Rami A. Dalloul, Hyun Soon Lillehoj, Masashi Okamura, Hang Xie, Wongi Min, Xicheng Ding, Robert A. Heckert · 2004 · Avian Diseases
92. Toll-Like Receptor 9-Dependent Macrophage Activation by Entamoeba histolytica DNA
    Catherine P. A. Ivory, Michael R. Prystajecky, Christian Jobin, Kris Chadee · 2007 · Infection and Immunity
93. Enhancement of immunogenicity of a virosome-based avian influenza vaccine in chickens by incorporating CpG-ODN
    Amirul Islam Mallick, Payvand Parvizi, Leah R. Read, Éva Nagy, Shahriar Behboudi, Shayan Sharif · 2010 · Vaccine
94. Induction of c-Myc-dependent cell proliferation through toll-like receptor 3 in head and neck cancer
    Ralph Pries, L. Hogrefe, Lei Xie, H Frenzel, C. Brocks, Claudia Ditz, Barbara Wollenberg · 2008 · International Journal of Molecular Medicine
95. CPG-7909 (PF-3512676, ProMune®): toll-like receptor-9 agonist in cancer therapy
    Yanal M. Murad, Timothy M. Clay, Herbert Kim Lyerly, Michael Andrew Morse · 2007 · Expert Opinion on Biological Therapy
96. Induction of CD8 T-Cell-Specific Systemic and Mucosal Immunity against Herpes Simplex Virus with CpG-Peptide Complexes
    Małgorzata M. Gieryńska, Uday Kumaraguru, Seong Kug Eo, Sujin Lee, Arthur Μ. Krieg, Barry T. Rouse · 2002 · Journal of Virology
97. CpG oligodeoxynucleotides as mucosal adjuvants
    Sumiko Iho, Jun‐ichi Maeyama, Fumiko Suzuki · 2015 · Human Vaccines & Immunotherapeutics
98. CpG oligodeoxynucleotides stimulate IFN-γ-inducible protein-10 production in human B cells
    Jörg Vollmer, Marion Jurk, Ulrike Samulowitz, Grayson B. Lipford, Alexandra Forsbach, Meike Wüllner, Sibylle Tluk, Hanna Hartmann, Andrea Kritzler, Christian Müller et al. · 2004 · Journal of Endotoxin Research
99. B Lymphocytes as Targets of the Immunomodulatory Properties of Human Amniotic Mesenchymal Stromal Cells
    Marta Magatti, Alice Masserdotti, Patrizia Bonassi Signoroni, Elsa Vertua, Francesca Romana Stefani, Antonietta Rosa Silini, Ornella Parolini · 2020 · Frontiers in Immunology
100. Induction of Interleukin-6 and Interleukin-12 in Bovine B Lymphocytes, Monocytes, and Macrophages by a CpG Oligodeoxynucleotide (ODN 2059) Containing the GTCGTT Motif
     Yan Zhang, Lisl K.M. Shoda, Kelly A. Brayton, D. Mark Estes, Guy H. Palmer, Wendy C. Brown · 2001 · Journal of Interferon & Cytokine Research